Remdesivir Gets Full FDA Approval as Coronavirus Treatment
Share
[aggregation-styles]
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
By Nathaniel Weixel | 22 Oct 2020
RELATED TOPICS:
Average Rate on a 30-Year Mortgage in the US Rises to Highest Level Since July
Housing /
8 hours ago
Cutting in Line? American Airlines’ New Boarding Tech Might Stop You at Now Over 100 Airports
Travel /
8 hours ago
MLB Will Test Robot Umpires at 13 Spring Training Ballparks Hosting 19 Teams
Sports /
8 hours ago
Jussie Smollett’s Conviction in 2019 Attack on Himself Is Overturned
Courts /
9 hours ago
Latest
Videos
Extra /
5 hours ago
North Korean Leader Says Past Diplomacy Only Confirmed US Hostility
Politics /
5 hours ago